In a 2022 study, researchers found the 5-year survival rate among people with lobular breast cancer was 93.6%. The survival rate drops significantly if cancer spreads to distant tissues. It’s not clear if having a CDH1 mutation affects the survival rate of people with lobular breast cancer.